Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial.

JHEP Rep · 2023 · PMC10031000 · PMID 36968218

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

marginally non-significantp = 0.059so close (0.05 < p ≤ 0.1)

Furthermore, there was a similar but marginally non-significant difference between the two groups in functional well-being score ( p = 0.059) and FACT-HEP total score ( p = 0.061) in the second month ( Fig. 5 ).

also in 411 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.